Compare ALVO & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALVO | VRTS |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 968.0M |
| IPO Year | N/A | 1995 |
| Metric | ALVO | VRTS |
|---|---|---|
| Price | $3.25 | $140.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $8.00 | ★ $158.00 |
| AVG Volume (30 Days) | ★ 384.9K | 69.3K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | ★ 18.24 |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | N/A |
| Revenue This Year | $13.28 | N/A |
| Revenue Next Year | $18.63 | $1.66 |
| P/E Ratio | ★ $18.20 | $133.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $121.61 |
| 52 Week High | $11.85 | $214.88 |
| Indicator | ALVO | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 49.28 |
| Support Level | $3.10 | $135.82 |
| Resistance Level | $3.83 | $147.15 |
| Average True Range (ATR) | 0.20 | 6.10 |
| MACD | -0.00 | -0.56 |
| Stochastic Oscillator | 13.27 | 61.54 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.